Methods for targeting solid tumor stem cells in a solid tumor using a notch4 receptor antagonist

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7850961
SERIAL NO

11529869

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A small percentage of cells within an established solid tumor have the properties of stem cells. These solid tumor stem cells give rise both to more tumor stem cells and to the majority of cells in the tumor that have lost the capacity for extensive proliferation and the ability to give rise to new tumors. Thus, solid tumor heterogeneity reflects the presence of tumor cell progeny arising from a solid tumor stem cell. We have developed a xenograft model in which we have been able to establish tumors from primary tumors via injection of tumors in the mammary gland of severely immunodeficient mice. These xenograft assay have allowed us to do biological and molecular assays to characterize clonogenic solid tumor stem cells. We have also developed evidence that strongly implicates the Notch pathway, especially Notch 4, as playing a central pathway in carcinogenesis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THE REGENTS OF THE UNIVERSITY OF MICHIGAN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Al-Hajj, Muhammad La Jolla, US 21 616
Clarke, Michael F Palo Alto, US 65 2958
Morrison, Sean J Ann Arbor, US 17 533
Wicha, Max S Ann Arbor, US 31 797

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation